4Tissue
The computed 12-month bankruptcy probability of 4Tissue is 1.1% (low). The 2025 annual accounts show equity of €845k and a net result of €-727k. Equity is growing by ~74.3% per year across the filed fiscal years. Its solvency ranks better than 52% of 54 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €845k |
| Net result | €-727k |
| Better than sector | 52% |
| Active | 3 yrs |
Mixed profile: strong on stability, weaker on profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 33.0% | 31.7% | |
| Net result | €-727k | €8k | |
| Equity | €845k | €31k | |
| Gross operating margin | €328k | €30k | |
| Total assets | €2.56M | €156k |
| Fiscal year | 2025 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €17k |
| Net profit | €-727k |
| Cash flow | €62k |
| Staff costs | €310k |
| Income taxes | €-40k |
| Dividends | - |
| Total assets | €2.56M |
| Equity | €845k |
| Debt | €1.71M |
| of which ≤ 1y | €179k |
| of which > 1y | - |
| Working capital | €1.73M |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 10.66 |
| Quick ratio | 10.66 |
| Working capital ratio | 67.6% |
| Solvency | 33.0% |
| Debt / equity | 2.03 |
| Long-term debt ratio | - |
| Interest coverage | 22.27 |
| Gross margin | - |
| Net margin | - |
| ROA | -28.4% |
| ROE | -86.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.56M |
| Fixed assets | 21/28 | €650k |
| Intangible fixed assets | 21 | €584k |
| Tangible fixed assets | 22/27 | €67k |
| Current assets | 29/58 | €1.91M |
| Amounts receivable within one year | 40/41 | €732k |
| Investments | 50/53 | €355k |
| Cash & bank | 54/58 | €122k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.56M |
| Equity | 10/15 | €845k |
| Contributions / capital | 10/11 | €1.91M |
| Accumulated profits (losses) | 14 | €-1.07M |
| Amounts payable | 17/49 | €1.71M |
| Amounts payable within one year | 42/48 | €179k |
| Trade debts payable within one year | 44 | €141k |
| Income statement | ||
| Gross operating margin | 9900 | €328k |
| Operating result | 9901 | €-772k |
| Financial income | 75 | €6k |
| Financial charges | 65 | €785 |
| Result before taxes | 9903 | €-767k |
| Income taxes | 67/77 | €-40k |
| Net result for the period | 9904 | €-727k |
| Result to be appropriated | 9905 | €-727k |
-
An Van Den BuickeSole directorState Gazette act 23055999 (25-04-2023)Current17-03-2023 → present
Former directors (1)
-
VAN DEN BULCKE AnSole directorState Gazette act 23055999 (25-04-2023)Former- → 17-03-2023
| NACE primary | Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden(32500) |
| Legal form | Private limited company(610) |
| Incorporation | 17-03-2023 |
| Status | Active |
| Postal code | 9052 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44082B0134/00G000 | Flanders | 9,157 m² | 1 · 2,487 m² | 20.2 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
25-02-2025 Capital increase of €999,800 to €999,800
- €0 → €999.800
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 999800.0,
"delta_eur": 999800.0,
"before_eur": 0.0,
"_arith_derived": "before",
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 4999,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 200.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 999800.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-25",
"filing_date": "2025-02-21",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-02-10",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0799.669.186",
"name_full": "4Tissue",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"vijf volmachten",
"de geco\u00F6rdineerde tekst van de statuten"
],
"shareholders_after": [],
"share_classes_after": []
}25-04-2023 1 director appointed, 1 resigning correction
- An Van Den Buicke, Enig bestuurder
- VAN DEN BULCKE An, Enig bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "enige_bestuurder",
"person": {
"rrn": null,
"name": "VAN DEN BULCKE An",
"address": "Pinksterbloemstraat 44, 9030 Mariakerke (Gent)",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "rechtzetting",
"subkind": "rectification",
"via_org": null,
"statutory": "niet_statutair",
"compensated": null,
"effective_date": "2023-03-17",
"evidence_quote": "De aandeelhouders bevestigen dat het hun bedoeling was om mevrouw VAN DEN BULCKE An, wonende te Pinksterbloemstraat 44, 9030 Mariakerke (Gent), te benoemen tot enige (niet-statutaire) bestuurder van de Vennootschap.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "enige_bestuurder",
"person": {
"rrn": null,
"name": "An Van Den Buicke",
"address": "Pinksterbloemstraat 44, 9030 Mariakerke (Gent)",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "rechtzetting",
"subkind": "rectification",
"via_org": null,
"statutory": "niet_statutair",
"compensated": null,
"effective_date": "2023-03-17",
"evidence_quote": "Voor zoveel als nodig bevestigen de aandeelhouders hierbij (a) het ontslag van Robium BV als bestuurder van de Vennootschap, en (b) de benoeming van An Van Den Buicke als bestuurder van de Vennootschap voor een onbepaalde duur, telkens met ingang vanaf 17 maart 2023:",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": "An Van Den Buicke",
"rep_rotation_old_rep": "VAN DEN BULCKE An",
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Robium BV",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "rectification",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Voor zoveel als nodig bevestigen de aandeelhouders hierbij (a) het ontslag van Robium BV als bestuurder van de Vennootschap",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "algemeen_beheerder",
"person": {
"rrn": null,
"name": "Adriaan de Leeuw",
"address": null,
"birth_date": null,
"profession": "Lasthebber",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Ad-Ministerie BV",
"address": "Brusselsesteenweg 66, 1860 Meise",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De aandeelhouders besluiten vervolgens om een bijzondere volmacht te verlenen aan Ad-ministerie BV, vertegenwoordigd door Adriaan de Leeuw, met zetel te Brusselsesteenweg 66, 1860 Meise, Belgi\u00EB, individueel bevoegd, evenals aan haar bedienden, aangestelden en lasthebbers, met mogelijkheid tot indepl",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-04-25",
"filing_date": "2023-04-14",
"act_kind_objet": "Rechtzetting Benoeming"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-03-23",
"unanimous": null
}
],
"is_correction": true,
"subject_company": {
"kbo": "0799.669.186",
"name_full": "4Tissue",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Ad-Ministerie BV",
"person_name": null,
"org_rep_person_name": "Adriaan de Leeuw",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | 4Tissue |